Filing Details

Accession Number:
0001140361-11-001840
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-01-07 12:53:43
Reporting Period:
2011-01-05
Filing Date:
2011-01-07
Accepted Time:
2011-01-07 12:53:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
707511 Regenerx Biopharmaceuticals Inc RGRX.OB Pharmaceutical Preparations (2834) 521253406
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1495790 S.a. Sinaf 11-13, Boulevard De La Foire
L-1528 Portugal N4 00000
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-01-05 1,296,297 $0.27 9,711,407 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrant (right to buy) Acquisiton 2011-01-05 1 $0.00 518,519 $0.38
Common Stock Common Stock Warrant (right to buy) Disposition 2011-01-05 1 $0.00 22,601 $4.06
Common Stock Common Stock Warrant (right to buy) Acquisiton 2011-01-05 1 $0.00 22,601 $0.38
Common Stock Common Stock Warrant (right to buy) Disposition 2011-01-05 1 $0.00 333,333 $2.75
Common Stock Common Stock Warrant (right to buy) Acquisiton 2011-01-05 1 $0.00 333,333 $0.38
Common Stock Common Stock Warrant (right to buy) Disposition 2011-01-05 1 $0.00 500,000 $1.60
Common Stock Common Stock Warrant (right to buy) Acquisiton 2011-01-05 1 $0.00 500,000 $0.38
Common Stock Common Stock Warrant (right to buy) Disposition 2011-01-05 1 $0.00 372,552 $1.74
Common Stock Common Stock Warrant (right to buy) Acquisiton 2011-01-05 1 $0.00 372,552 $0.38
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1 2011-07-07 2016-01-07 No 4 J Direct
0 2011-03-16 No 4 J Direct
1 2011-12-31 No 4 J Direct
0 2011-12-21 No 4 J Direct
2 2011-12-31 No 4 J Direct
0 2010-12-31 No 4 J Direct
3 2011-12-31 No 4 J Direct
0 2011-12-31 No 4 J Direct
4 2011-12-31 No 4 J Direct
Footnotes
  1. 1,219,512 of these shares were acquired by Chaumiere Consultadoria e Servicos SDC Unipessoal LDA ("Chaumiere"), which was a direct wholly-owned subsidiary of the Reporting Person, on October 8, 2009 pursuant to a purchase agreement dated as of September 30, 2009 with the Issuer that provides that the Issuer, rather than the holder, has all voting rights in respect of the shares through September 30, 2012, and that the holder may not transfer the shares through September 30, 2012 except for transfers to Affiliates (as defined therein). 1,052,631 of these shares were acquired by Chaumiere on April 13, 2009 pursuant to a purchase agreement with the Issuer that provides that the Issuer, rather than the holder, has all voting rights in respect of the shares through April 30, 2012, and that the holder may not transfer the shares through April 30, 2012 except for transfers to Affiliates (as defined therein).
  2. 1,034,482 of these shares were acquired by Chaumiere on December 10, 2008 pursuant to a purchase agreement with the Issuer that provides that the Issuer, rather than the holder, has all voting rights in respect of such shares through December 31, 2011, and that the holder may not transfer such shares through December 31, 2011 except for transfers to Affiliates (as defined therein). On June 29, 2010, Chaumiere merged with and into the Reporting Person. The Reporting Person is a direct wholly-owned subsidiary of Aptafin S.p.A.
  3. The Warrant was issued by the Issuer to the Reporting Person in consideration of the Reporting Person's purchase of Common Stock.
  4. The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant became exercisable on September 16, 2006.
  5. The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant became exercisable on December 12, 2006.
  6. The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant became exercisable on February 29, 2008.
  7. The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant became exercisable on December 10, 2008.